On 18th August 2021, the Extraordinary General Meeting of shareholders of the Company adopted resolutions concerning modification of paragraph 38 of the Company’s charter and adoption of a new consolidated text of the charter. An application to register the aforementioned modification was submitted at the National Court Register within the prescribed term.
4Cell Therapies -